FESO – European Stroke Organisation https://eso-stroke.org the voice of stroke in Europe Mon, 17 May 2021 09:37:55 +0000 en-GB hourly 1 https://wordpress.org/?v=6.8.3 Interview with Dr. Inna Lutsenko https://eso-stroke.org/interview-with-dr-inna-lutsenko/ Tue, 27 Apr 2021 05:30:11 +0000 https://eso-stroke.org/?p=18408 <p>The post Interview with Dr. Inna Lutsenko first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }
This year, as part of the Member newsletter, we are featuring individuals who have demonstrated enthusism and motivation to take on tasks, join a commmittee and make a mark on the organisation all while growing their careers.
Lutsenko
For April we hear from Dr. Inna Lutsenko, Kyrgyz State Medical Academy after I.K, Akhunbaev, Advanced Training Department. Inna is a regular contributing author to the ESO blog, former ESO EAST national delegate for Kyrgyzstan and active social media user. Inna has been an ESO member since 2015, progressively taking on more responsibility as well as participating in various ESO activities including; ESO EAST annual workshops, the Department to Department Visit Programme, and Edinburgh Stroke Research Workshop.  She has also sucessfully presented several posters at the annual ESOC. We chat with Inna about the steps she took in ESO and how she grew along the way.

When did you first join ESO? Was there a person or event that encouraged you to become a member?


I would like to emphasize the positive influence of my first teacher in neurology, academician Professor Arstanbek Murzaliev, who is celebrating his 90th anniversary this year. Professor Murzaliev inspired us, his students, to maintain professional ties with colleagues abroad and encouraged us to bring changes to the field of neurology in our country based on the latest achievements of neurological science worldwide. This is precisely what became the motivation for my participation in the ESO EAST Project, to which my mentor Professor Elmira Mamytova kindly invited me.

I have a strong and a vivid memory of my first participation in the ESO event taking place in Georgia during the 6th World Stroke Organisation’s regional meeting “Tbilisi 2015: Stroke diagnosis and prevention”.  At this conference I represented Kyrgyzstan with a speech on stroke services in my country in the workshop “Stroke in the Black Sea Region and Central Asia”. This meeting was the first step in establishing a network of stroke professionals in Eastern Europe and Central Asia in cooperation with leaders in stroke services around the world. I clearly remember my impression of the reports of Professor Nathan Bornstein, Professor Valeria Caso and Professor Robert Mikulik. Most of all, I was impressed by the idea that recognized European leaders in the field of stroke research would share their experiences and help organize stroke services for the countries participating in the ESO EAST project.


You were a founding delegate of ESO EAST, how has this impacted your activities outside of ESO?


In 2015 the European Stroke Organisation (ESO) launched the ESO EAST (European Stroke Organisation – Enhancing and Accelerating Stroke Treatment) project. The aim of this project is to facilitate the implementation of new proven approaches in stroke diagnostics, management and treatment. Kyrgyzstan joined the ESO EAST project in 2015 and I had the honor of representing the interests of my country.

I am very grateful to my team, with whom I worked during the period 2015-2020: highly motivated student volunteers, residents of hospitals in Bishkek and doctors from all regions of Kyrgyzstan. We were able to introduce the RES-Q stroke registry in regional capitals and rural areas, established cooperation with the educational organization Angels Initiative, conducted many trainings on assessment and evidence-based stroke treatment for hospital doctors, as well as doctors and paramedics of Bishkek’s emergency medical center. There we were also able to implement the NIHSS scale to assess all patients suffering from stroke and develop an algorithm for recognizing the first symptoms of stroke, called “SOKKU”, the Kyrgyz analogue of FAST. I would like to emphasize that I was inspired by both the ESO leaders as well as the attended professional trainings to promote evidence-based initiatives in my country.


You were awarded a Department to Department Visit Programme grant in 2019. Would you recommend this programme to others?


In December 2019 I had the opportunity to stay at the San Camillo Hospital in Rome, Italy, for one week by invitation of Professor Francesca Romana Pezzella, who I met during her visits to Kyrgyzstan in 2017 in her role as the ESO expert for the „Roadmap for Stroke“ project. I participated as part of the working group in this project and was working with Dr. Pezzella during her visits in Kyrgyzstan as well as online. My special focus in research always has been the stroke services organization, stroke pathways and stroke management. Having been involved in the changes of stroke management in Kyrgyzstan, I was planning to observe an entire stroke pathway  at the San Camillo Hospital, which is the “hub” for stroke management in Italy’s Lazio region.

The atmosphere in the stroke and general neurology departments at the San Camillo Hospital was welcoming and positive. Doctors and nurses were friendly to all visiting specialists, they collaborated and included them in the daily routine very fast. I also learned that this special atmosphere of “cheerfulness”, optimism, mutual assistance and positive emotions is very typical for Italy.

We took an example of our colleagues from Italy, who also struggled to implement changes, such as new stroke scales, electronic records, robotic pharmacy and highly functioning neuroimaging inside the same pavilions, for years, but finally made it possible due to their highly collaborative work.


Which ESO meetings you attended can you recommend for young colleagues in order to change their careers towards professional growth and expanding collaboration?


I would like to emphasise the importance of participating in such ESO initiatives as the ESO Summer School and the ESO Edinburgh Stroke Workshop for young colleagues. Where else will you have the opportunity to get first-hand knowledge from professors while also having direct access to them for questions and discussions during the coffee breaks?

At the same time, I would like to encourage my colleagues not only to gain knowledge for their personal growth, but also to invest part of their time and expertise in representing and growing ESO in their respective countries, because we are progressing only by sharing what we have received. This also is my motto in my life and professional environment.

<p>The post Interview with Dr. Inna Lutsenko first appeared on European Stroke Organisation.</p>

]]>
FESO Interview with Francesco Arba https://eso-stroke.org/feso-interview-with-francesco-arba/ Mon, 27 Jul 2020 06:30:23 +0000 https://eso-stroke.org/?p=15119 <p>The post FESO Interview with Francesco Arba first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }


To qualify as a FESO, members must demonstrate scientific quality and a willingness to actively volunteer in ESO. There are no age requirements, but FESO must meet minimum standards. FESO receive additional benefits, including participation in the Council of Fellows. Visit our website for more information on how to distinguish yourself as a FESO.

We hope you enjoy getting to know the Fellows who participate in the 2020 interview series and thank them in advance for taking the time to share with our readers.

For the July issue of the ESO member newsletter, we present Francesco Arba MD, PhD, FESO, Stroke Unit, AOU Careggi, Florence, Italy. Francesco is an active FESO.

What are your main fields of interest in stroke medicine and research?


My main field of interest is acute stroke therapy and management. I am particularly interested in imaging markers for ischemic and hemorrhagic stroke, such as early ischemic changes, small vessel disease, blood-brain-barrier disruption, predictors of hemorrhage expansion. Expanding knowledge about all these markers should help design of clinical trials for acute stroke therapy, eventually optimizing clinical outcomes of patients.


What is the role of ESO in facilitating and promoting the projects you are coordinating or where you are involved?


It is stimulating to be part of a great world platform such as ESO. It is a major opportunity to share ideas, get involved in research projects, discuss about management of stroke patients. In ESO I found enthusiastic colleagues and enjoyable friends to work with.


What do you expect from ESO in the future to support research?


ESO is a main reference for all stroke professionals all over the world. I would expect from ESO to keep on this tremendous effort, possibly involving more countries, and to maintain the usual excellent quality of conferences and meetings. I would expect an open, diffuse, high-level science community as already is. ESO gives many opportunities for those interested to be part of it.


What do you think a mentor should do to support the projects and the career of a mentee and, conversely, what should a mentee expect from a mentor?


I had the fortune to have mentors of highest profile, and this has been a great opportunity to gain experience and learn a lot, of course. They were supportive, gave me the chance to expand the ideas to a wider context, to seek for collaborations and funding. They highlighted the importance of building an international network of collaborators. A mentee should expect availability to discuss ideas and willingness to instill passion. The mentor is a model for the mentee, and learning from someone you consider a model is fundamental in this beautiful work.

<p>The post FESO Interview with Francesco Arba first appeared on European Stroke Organisation.</p>

]]>
FESO Interview with Keith Muir https://eso-stroke.org/feso-interview-with-keith-muir/ Mon, 29 Jun 2020 11:02:49 +0000 https://eso-stroke.org/?p=14898 <p>The post FESO Interview with Keith Muir first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }


To qualify as a FESO, members must demonstrate scientific quality and a willingness to actively volunteer in ESO. There are no age requirements, but FESO must meet minimum standards. FESO receive additional benefits, including participation in the Council of Fellows. Visit our website for more information on how to distinguish yourself as a FESO.

We hope you enjoy getting to know the Fellows who participate in the 2020 interview series and thank them in advance for taking the time to share with our readers.

For the June issue of the ESO member newsletter, we present Keith Muir, SINAPSE Professor of Clinical Imaging & Consultant Neurologist, University of Glasgow, Queen Elizabeth University Hospital, FESO. Keith is an active FESO and Chair of the European Stroke Science workshop.

What are your main fields of interest in stroke medicine and research?


Use of imaging to guide clinical trial design; acute treatments, particularly improving reperfusion; CADASIL.


What is the role of ESO in facilitating and promoting the projects you are coordinating or where you are involved?


The ESO Conference is a major opportunity to interact with collaborators and to disseminate research updates and findings.


What do you expect from ESO in the future to support research?


Promoting and supporting inter-institutional secondments and interactions for the purpose of research collaboration. Continue to have a strong research-led agenda for meetings such as the ESO Stroke Science Workshop, summer school and the main ESO conference.


What do you think a mentor should do to support the projects and the career of a mentee and, conversely, what should a mentee expect from a mentor?


Try to guide by encouraging new ideas, identifying funders and collaborators, and giving a wider context to the project . Seek opportunities to work with and learn from other services and research groups.

Availability, encouragement, and honesty.

<p>The post FESO Interview with Keith Muir first appeared on European Stroke Organisation.</p>

]]>
FESO Interview with Annette Fromm https://eso-stroke.org/feso-interview-annette-fromm/ Mon, 27 Apr 2020 06:50:48 +0000 https://eso-stroke.org/?p=13905 <p>The post FESO Interview with Annette Fromm first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }


To qualify as a FESO, members must demonstrate scientific quality and a willingness to actively volunteer in ESO. There are no age requirements, but FESO must meet minimum standards. FESO receive additional benefits, including participation in the Council of Fellows. Visit our website for more information on how to distinguish yourself as a FESO.

We hope you enjoy getting to know the Fellows who participate in the 2020 interview series and thank them in advance for taking the time to share with our readers.

For the April issue of the ESO member newsletter, we present Annette Fromm, MD PhD MSc (Stroke) FESO, Bergen Stroke Research Group, Center for Neurovascular Diseases, Department of Neurology, Haukeland University Hospital, Bergen, Norway. Annette is a graduate of the ESO supported, European Master Programme in Stroke Medicine and active in ESO and the Norwegian Stroke Organisation. In addition to being an FESO, she is a member of the WISE working group and participated in the ESO national society stroke meetings as the Secretary of the Norwegian Stroke Organisation.

What are your main fields of interest in stroke medicine and research?


My clinical work is mainly focused on the field of acute stroke treatment and monitoring, including the implementation of new evidence into clinical practice. I largely enjoy the tight collaboration with specialists from all medical fields related to neurovascular medicine at our hospital, in order to continuously improve routines and standard procedures. The last months we have been working a lot on the adaptation of our acute stroke pathways and stroke investigation procedures in light of the additional challenges related to the COVID-19 pandemic.

Neurosonology is a subject of special interest to me. I am truly amazed by the various opportunities the available methods deliver both regarding acute phase monitoring options, causal and preventive investigation options, and the possibility to visualize and understand complex hemodynamic contexts impacting further decision making.

As member of the Bergen Stroke Research Group, the research I am involved in is diverse, combining the fields of acute stroke treatment and prehospital alert, Neurosonology, secondary prevention and the wide field of young stroke.


What is the role of ESO in facilitating and promoting the projects you are coordinating or where you are involved?


ESO has gained worldwide recognition as one of the leading stroke societies, with a profile of responsibility, trustworthiness and passion for the field. I understand ESO as a great platform for exchange and collaboration between researchers and clinical practitioners. The work on and continuous renewal of guidelines and expert opinions based on newly gathered knowledge is especially important to me, providing a valuable foundation to follow, re-think or improve own research questions.


What do you expect from ESO in the future to support research?


I expect ESO to keep its open and including profile, as the ESO society makes multicenter and international cooperation and networking easy, pushing the stroke field further in many directions. Possibly ESO may function as an umbrella society for large scale international research proposals, utilizing the enormous professional variety among its members, and being able to involve a large number of research institutions worldwide.


What do you think a mentor should do to support the projects and the career of a mentee and, conversely, what should a mentee expect from a mentor?


A mentor should be open to new ideas of the mentee, help to adjust and support them, guide professional development, encourage self-reflection, suggest alternative directions and, if possible, provide a network to follow those.

A mentee may benefit from several mentors covering the mentee`s need for guidance in different areas of their development. The mentee may bring along curiosity and passion, and should be encouraged to ask for guidance and mentorship whenever needed.

<p>The post FESO Interview with Annette Fromm first appeared on European Stroke Organisation.</p>

]]>
FESO Interview with Gian Marco De Marchis https://eso-stroke.org/feso-interview-with-gian-marco-de-marchis/ Mon, 23 Mar 2020 10:14:36 +0000 https://eso-stroke.org/?p=13588 <p>The post FESO Interview with Gian Marco De Marchis first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }


To qualify as an FESO, members must demonstrate scientific quality and a willingness to actively volunteer in ESO. There are no age requirements, but FESO must meet minimum standards. FESO receive additional benefits, including participation in the Council of Fellows. Visit our website for more information on how to distinguish yourself as a FESO.

We hope you enjoy getting to know the Fellows who participate in the 2020 interview series and thank them in advance for taking the time to share with our readers.

For the March issue of the ESO member newsletter, we have an interview with Gian Marco De Marchis, MD MSc FESO, Deputy Director of the Stroke Unit, University Hospital Basel, Switzerland. Gian Marco De Marchis is an active Fellow who serves as a member of the ESO guideline working group on intravenous thrombolysis as well as the public relations and social media committees.

How did ESO Contribute to your own research?


ESO conferences are a platform for top-quality contents and trials. ESO helped me a lot, mainly through the networking occurring at ESO conferences. For instance, at the ESOC in Barcelona in 2016, I met clinical researchers interested in the early use of direct oral anticoagulants (DOAC) after a stroke. We decided to join forces, merged our data sets, and decided to address questions on DOAC that were left open in the four pivotal clinical trials. These patient data came from Europe, North America and Japan. The collaboration resulted in a series of joint publications. ESOC meeting act as catalysators for such collaborations across countries.


What do you see as the next horizons in early secondary stroke prevention?


There are novel therapeutic targets worth exploring to prevent recurrent strokes. Coagulation factor XI is one of them. People with severe factor XI deficiency – also known as Haemophilia C – have a 43% lower incidence of MI/stroke/TIA, without an increase in intracranial haemorrhage (Preis M et al, Blood 2019). Hence, inhibition of FXIa is a promising strategy to prevent strokes. This is also backed by Mendelian randomization evidence (Gill D et al, Stroke 2018). Two phase II, placebo controlled randomized clinical trials – PACIFIC and AXIOMATIC – are currently testing two novel oral FXIa inhibitors on a background of antiplatelet therapy in patients with non-cardioembolic stroke. This brings new hope in stroke prevention.


What about precision medicine?


Precision medicine has the potential to let us individualize prevention strategies to the patient in front of us, moving away from the “one size fits all strategy”. For instance, clopidogrel – a prodrug – needs to be activated by hepatic CYP2C19, in order to work. But one in five patients does not metabolize the drug appropriately and may, thus, be at higher risk of suffering a recurrent stroke. This was shown nicely in a post-hoc analysis from CHANCE. An alternative to clopidogrel may be ticagrelor, which does not require hepatic activation – I am looking forward to hearing the full THALES trial results (ASS+Ticagrelor vs. ASS). If THALES is positive, the question of CYP2C19 genotyping may flare up again, as poor clopidogrel metabolizers may benefit from ticagrelor combined with aspirin.


How can we achieve these goals?


Clinical trials are getting more and more demanding in terms of resources. To win this challenge, we need an alliance across stakeholders – academia, public agencies, pharmaceutical companies and foundations. When a practice-changing article is published in a top medical journal, it is a win-win situation for patients, investigators and sponsors.

We are conducting this interview amid the COVID19-pandemics – we need everybody’s help to curb the infection rate and save human lives. Both the public and private sectors are essential to develop, produce and test a vaccine and antiviral treatments in large scale. This teaching also applies to acute stroke management and prevention. When we work all together, we are much stronger.


What levels of networking do you see?


There are several layers of networking – at hospital, national and international level.

At hospital level, the big strength is to have all specialists under the same roof, which facilitates interdisciplinary exchange. For instance, we regularly re-evaluate our acute stroke pathway together with the neuroradiology team to update and optimize processes. Only thanks to the help of neuroradiology and emergency departments, we can achieve door-to-needle times 20 minutes. On the other hand, an important job of us as vascular neurologists is to do everything we can to let interventional neuroradiologists get to the occluded artery as fast as possible. For secondary prevention, we frequently interact with cardiologists, from whom we also learn a lot, as they approach the same issue from another, equally important, perspective

At the national level, in Switzerland, all stroke trialists meet yearly to discuss ongoing and planned research projects. This is a wonderful meeting, which is organized by the Swiss Stroke Society. A vital research resource at national level is the Swiss Stroke Registry (SSR): since 2014, more than 60’000 patients treated at Swiss Stroke Units and Centres have been prospectively recorded and followed-up through the SSR. Several research projects are stemming from the SSR. This is a national team effort and the credit goes to every Stroke Unit and Stroke Center.

At international level, ESO achieved –very rapidly and successfully– to connect a whole Continent in the fight against stroke. The annual conference has become a yearly milestone, after which stroke care is regularly improved. Young stroke researchers deeply appreciate ESO’s effort towards younger generations and gender balance. In this sense, I wish to acknowledge Eivind Berge, who sadly passed away – I was honoured when Eivind, on behalf of the guideline committee, asked me if I was willing to join the guideline committee on intravenous thrombolysis. Working together with top experts from different countries is an enriching experience. ESO makes that possible.

What do you do outside of work?

I spend my free time mostly with my family; my wife – who is an architect and cellist – and two kids. Their smiles are essential and they are incredibly supportive. I also enjoy mountain biking an cooling, mainly Italian dished like Spaghetti alle Vongole.

<p>The post FESO Interview with Gian Marco De Marchis first appeared on European Stroke Organisation.</p>

]]>
FESO Interview with Eleni Korompoki https://eso-stroke.org/feso-interview-with-eleni-korompoki/ Mon, 24 Feb 2020 11:14:23 +0000 https://eso-stroke.org/?p=13521 <p>The post FESO Interview with Eleni Korompoki first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }


To qualify as an FESO, members must demonstrate scientific quality and a willingness to actively volunteer in ESO. There are no age requirements, but FESO must meet minimum standards. FESO receive additional benefits, including participation in the Council of Fellows. Visit our website for more information on how to distinguish yourself as a FESO.

We hope you enjoy getting to know the Fellows who participate in the 2020 interview series and thank them in advance for taking the time to share with our readers.

For the February issue of the ESO member newsletter, we bring you 2 interviews to begin the 2020 FESO series. Gian Marco De Marchis, MD MSc Priv. Doz. FESO, Neurology & Stroke Center, Universtiy Hospital Basel, Switzerland took the chance to interview Eleni Korompoki, MD, PhD, FESO, Department of Clinical Therapeutics, University of Athens, Greece.

Eleni Korompoki has been actively engaged in the ESO since 2015. She currently serves as a member of the ESO Guideline Board and participates in the development of the ESO Guidelines on secondary stroke prevention. She is also a founding member of the Hellenic Stroke Organisation, an Organisational member of ESO, where she currently serves in the Board of Directors. Eleni Korompoki is committed to promoting the vision of the ESO to reduce stroke burden and improve stroke management at national and European level.

How did your interest in the heart-brain interaction arise?


During my undergraduate studies I had developed a special interest in brain sciences. However, after graduating from medical school I decided to specialize in Internal Medicine so that my approach as a physician would be more holistic. The Department of Clinical Therapeutics, where I carried out my specialty training has a longstanding tradition in cardiovascular medicine. Early in my research career I decided that my research would be based on the link between the cardiovascular system and the brain. Thus, my PhD thesis was focused on the heart and brain connection at the early stages of essential hypertension. Later on, during my specialty training I decided to pursue more practical skills in heart and brain interaction and my mentor, Dr. Kostas Vemmos, inspired me to do my post-doctoral fellowship in stroke medicine. Stroke medicine represents an exceptional model on heart and brain connection considering that most causes of stroke are related to the cardiovascular system; on the other hand effective cardiovascular prevention may reduce stroke risk. Upon moving to the UK for further training in stroke medicine and stroke research I had plenty of opportunities to incorporate and translate all my knowledge and experience in cardiovascular medicine and stroke in high quality clinical research on heart and brain connection working together with Prof. Roland Veltkamp.


What are the big challenges in stroke medicine in Greece?


Acute stroke management in Greece still has room for improvement. A comprehensive national strategy for stroke management over the cycle of care and for mitigating the social consequences is lacking. Despite the presence of national guidelines, endovascular thrombectomy in Greece is not the standard of care. Limited resources, lack of systems of implementation and lack of a comprehensive national strategy are amongst the factors responsible for the gap between evidence based medicine and clinical practice.

Stroke patients are admitted in Internal Medicine and Neurology departments, since the existing specialized stroke units are very few. Moreover, those few stroke units are short-staffed. In addition, there is shortage of interventionists who can perform endovascular thrombectomy. Furthermore, there are serious obstacles in terms of access to rehabilitation services for these patients, since there is a limited number of public centres, located mainly in urban areas. Consequently, after the acute phase of stroke, patients are either transferred to private rehabilitation centres, where the cost is partly covered by Social Security Funds, or are discharged to their homes without participating in a rehabilitation program. According to the Greek tradition, provision of home care for chronically ill, disabled and elderly people is mainly provided either by relatives or by private carers, causing significant financial burden on families.

Consequently, the biggest challenge currently in Greece is to organise stroke units and rehabilitation centres, in accordance with the ESO standards within NHS, staffed by a multidisciplinary team with specialized knowledge in stroke care.


What is your advice to young women contemplating a career in stroke medicine?


Women are under-represented in stroke medicine, especially in the fields of leadership and mentoring. Therefore, the participation of young women in these areas should be highly encouraged. As a member of WISE (Women Initiative for Stroke in Europe) I strongly believe that there should be mutual support amongst women, so that they successfully plan their career development as well as their personal life aspects.

Women who work as stroke care physicians can be at the same time spouses and mothers and in many occasions they need to step-down during their careers (e.g. for maternity leave). This usually happens at the time they are transitioning to a more senior role in their working environment. Taking into account my personal experience I would like to encourage young women who are considering a career in stroke medicine that it a feasible choice, despite the fact that it seems challenging. Stroke medicine offers a lot of opportunities depending on the personal circumstances. For example, soon after having my baby I stepped-down on my clinical career and I did post-doctoral research in the UK, which did not involve out-of-hours work. When my circumstances allowed, I returned to full-time clinical work and I also undertook a more senior post in stroke research, having gained a lot of experience during my post-doctoral fellowship. As a woman, I am keen on supporting other female colleagues and most of my mentees are women. It is very encouraging that in ESO there are women who have emerged as role models and they are exceptional examples. These colleagues have demonstrated significant achievements in all aspects of stroke care and research and, therefore, more and more women should be encouraged to take up such roles!


What are the main dos and don`ts for a health mentor/mentee relationship?


The relationship between mentors and mentees is dynamic, interactive and usually lifelong. Like any other relationship, a mentor-mentee relationship takes work from both sides. The mentor’s role is to provide guidance, encouragement, inspiration and support, while the mentee’s role is to be motivated, committed and proactive. It is very important to regularly evaluate and assess whether the goals and expectations from both sides are met.  Clear, open, honest communication will help both sides to determine whether the relationship has run its course and if it should be terminated.  Respect is a key point from both sides and one of the most important factors in determining the success of a good professional relationship. Honesty and trust are essential in a successful partnership. Commitment is key to making the partnership work. The mentee should be respectful to the mentor, for their achievements and their commitment to mentoring, since the mentor is spending valuable time for mentoring, often voluntarily. Mutual respect sets clearer boundaries that keep the relationship professional and on the right track. It is also important to have a clear idea of respective roles, as well as be aware of any explicit or hidden biases that could potentially affect the relationship. Although many mentor-mentee relationships usually progress into friendship, they should be initiated as professional collaboration.

<p>The post FESO Interview with Eleni Korompoki first appeared on European Stroke Organisation.</p>

]]>
FESO Interview with Joan Martí-Fàbregas https://eso-stroke.org/feso-interview-with-joan-marti-fabregas/ Sun, 23 Feb 2020 08:29:19 +0000 https://eso-stroke.org/?p=13478 <p>The post FESO Interview with Joan Martí-Fàbregas first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-k9109m0i-10934c3fe002a3b703e25ad2fa8fb099{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }

To qualify as an FESO, members must demonstrate scientific quality and a willingness to actively volunteer in ESO. There are no age requirements, but FESO must meet minimum standards. FESO receive additional benefits, including participation in the Council of Fellows. Visit our website for more information on how to distinguish yourself as a FESO.

We hope you enjoy getting to know the Fellows who participate in the 2020 interview series and thank them in advance for taking the time to share with our readers.

For the February issue of the ESO member newsletter, we bring you 2 interviews to begin the 2020 FESO series. The first one features Joan Martí-Fàbregas, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain. Joan Martí-Fàbregas is an active member of the Guideline Publication Subcommittee.

What are your main fields of interest in stroke medicine and research?

​I am focused on clinical investigation about intracerebral hemorrhage and on reperfusion therapies in acute ischemic stroke (intravenous thrombolysis and mechanical thrombectomy)

What is the role of ESO in facilitating and promoting the projects you are coordinating or where you are involved?

As stated in the website, ESO is the voice of stroke in Europe.  ESO is a young society that has achieved in a few years a spectacular implantation. Nowadays, any professional who wants to be up to date about stroke and interact with other European professionals has to be a member of ESO. Being a member of ESO is an honor and an opportunity for professional growth and improvement in your research goals. Collaboration in the writing of guidelines is important and so is trying to increase the dissemination of the guidelines.

What do you expect from ESO in the future to support research?

ESO brings the opportunity to multi-center and multi-national collaboration. This collaboration should be enabled by removing administrative obstacles as far as possible, creating research networks and facilitating access to funding.

What do you think a mentor should do to support the projects and the career of a mentee and, conversely, what should a mentee expect from a mentor?

The main function of the mentor is to help the mentee think. Whoever is now acting as a mentor also had a mentor; it is a chain of knowledge transmission that allows us to face the challenges of knowledge. A good friend passed on to me his 4 rules for success in professional life that I usually recommend: focus, discipline, self-esteem and passion.

A mentee should expect to find an enthusiastic mentor, who enjoys his work, who knows how to listen and treat the mentee with respect and guide him o her. Contact with the mentor must be a continued effort, lasting over time. Priorities and objectives must be identified. The mentee must also know that the mentor does not know everything, even the most experienced person in one subject is a novice in another.

What are your main fields of interest in stroke medicine and research?


​I am focused on clinical investigation about intracerebral hemorrhage and on reperfusion therapies in acute ischemic stroke (intravenous thrombolysis and mechanical thrombectomy)


Second Headline


Second text

<p>The post FESO Interview with Joan Martí-Fàbregas first appeared on European Stroke Organisation.</p>

]]>
FESO Interview with Linxin Li https://eso-stroke.org/feso-interviewlinxinli/ Fri, 29 Nov 2019 11:33:23 +0000 https://eso-stroke.org/?p=12635 To qualify as an FESO, members must demonstrate scientific quality and a willingness to actively volunteer in ESO. There are no age requirements, but FESO must meet minimum standards. FESO receive additional benefits, including participation in the Council of Fellows. Visit our website for more information on how to distinguish yourself as a FESO. We […]

<p>The post FESO Interview with Linxin Li first appeared on European Stroke Organisation.</p>

]]>

To qualify as an FESO, members must demonstrate scientific quality and a willingness to actively volunteer in ESO. There are no age requirements, but FESO must meet minimum standards. FESO receive additional benefits, including participation in the Council of Fellows. Visit our website for more information on how to distinguish yourself as a FESO.

We hope you enjoy getting to know the Fellows who participate in the 2019 interview series and thank them in advance for taking the time to share with our readers.

For the November/December issue of the ESO member newsletter, we bring you 2 interviews.  The first one features Linxin Li, Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, UK. Linxin Li is an active member of the ESO Young Stroke Physicians and Researchers (YSPR) committee as well as Co-editor and frequent contributor of the ESO Blog – The Voice of Stroke in Europe.

What are your main fields of interest in stroke medicine and research?

My main research focuses on the aetiological classification of stroke and I’m particularly interested in cryptogenic stroke, where no known cause is identified after standard diagnostic work-up. My current work aims to use traditional epidemiological methods as well as more advanced imaging tools to better understand the likely causes of cryptogenic stroke. The other growing interest of mine is about the role of susceptibility and control of traditional modifiable risk factors for strokes at younger ages.

What is the role of ESO in facilitating and promoting the projects you are coordinating or where you are involved?

ESO provides excellent opportunities for building bridges among stroke clinicians and researchers across Europe and more increasingly around the world. Participating in the ESO summer school, winter school and conferences has broadened my view as well as research networks, not only in the areas that I’m particularly interested in but also about the frontiers in stroke medicine more generally. I have also gained invaluable experiences in areas that I would not have gained by my day-to-day job through the work with the ESO Young Stroke Physicians and Researchers (YSPR) Committee, the ESO blog and the European Stroke Journal.

What do you expect from ESO in the future to support research?

The ESO conference (ESOC) and the European Stroke Journal (ESJ) are already brilliant platforms and I have no doubt both will grow even more influential in the very near future. Opportunities to nurturing younger generals of stroke researchers will probably also grow through various ESO educational activities. Finally, the Stroke Action Plan Europe 2018-2030 will most likely nests important research opportunities across different disciplines and between different countries.  

What do you think a mentor should do to support the projects and the career of a mentee and, conversely, what should a mentee expect from a mentor?

Always being available to guide and support is perhaps what I cherish most from my mentors.  Their constant passion and curiosity about what they are doing is also particularly inspirational. I guess a mentor is there to lead you into an area that is interesting, important and will ultimately become an expertise of yours. Whilst it is important to have someone there to guide and advise, the mentees should also learn to become independent researchers themselves.

<p>The post FESO Interview with Linxin Li first appeared on European Stroke Organisation.</p>

]]>
New Feature – Paper of the Month https://eso-stroke.org/new-feature-paper-of-the-month/ Mon, 25 Nov 2019 11:20:59 +0000 https://eso-stroke.org/?p=12616 Starting November 2019, we are excited to present a new monthly feature – Paper of the Month. This feature was initiated by the Council of Fellows to highlight interesting and relevant papers published by ESO members or with special relevance to Europe. Paper of the Month nominations will come from the recently formed working  group […]

<p>The post New Feature – Paper of the Month first appeared on European Stroke Organisation.</p>

]]>

Starting November 2019, we are excited to present a new monthly feature – Paper of the Month.

This feature was initiated by the Council of Fellows to highlight interesting and relevant papers published by ESO members or with special relevance to Europe. Paper of the Month nominations will come from the recently formed working  group of the same name. Additionally all ESO members are invited to nominate appropriate papers for recognition as Paper of the Month. More details as well as an archive can be found on the Paper of the Month webpage.

Each paper will be presented in the second half of the month accompanied by a brief comment by a member of the group.

On behalf of the Paper of the Month group, we hope you enjoy the read!

Paper of the Month Group: Christine Roffe, Marie Louisa Zedde, Stefano Ricci, Augusto Zaninelli, Vladimir Nosal, Hughes Chabriat, Nishant Mishra, Anita Arsovska, Ana Fonseca, Diana Aguiar de Sousa, Mario Di Napoli, and Nicolas Martinez-Majander

November

This month’s paper is of particular interest as it addresses an area of clinical uncertainty which affects daily practice. Should we bridge with full dose heparin/low molecular weight heparin when faced with a patient in AF who has had a minor stroke? Altavilla et al’s large observational study suggests ‘no’. Both ischemic and haemorrhagic strokes were more frequent in the bridged group. However, the study is not randomized, and neither multivariate analysis nor propensity matching can fully exclude biases. However, while we are waiting for results of on-going clinical trials such as ELAN, these results should make us stop and think when considering bridging.

Anticoagulation After Stroke in Patients With Atrial Fibrillation To Bridge or Not With Low-Molecular-Weight Heparin?

Originally publishedhttps://doi.org/10.1161/STROKEAHA.118.022856 Stroke. 2019;50:2093–2100

<p>The post New Feature – Paper of the Month first appeared on European Stroke Organisation.</p>

]]>